US equities are leaning firmly bullish across most published research this week — with one loud contrarian voice warning of bubble conditions.
The constructive case, as laid out in recent third-party research, rests on earnings growth still running well above long-run averages, a projected 7–8% long-term EPS trajectory even as the AI capex cycle cools, and mega-cap tech reclaiming leadership on strong hyperscaler results. Historical work cited by analysts shows the S&P 500 breaking to new highs after long consolidations has typically delivered solid forward returns. Macro-focused commentary points to healthy credit data, resilient card spending, and a firm labor market as justification for current levels.
The dissenting view, from one prominent macro researcher, argues consensus is quietly pricing in 20%+ earnings growth for five straight years — unrealistic, in that camp's view, given hidden leverage in levered ETFs, options, and margin lending.
Sector-wise, some analysts favor overlooked quality — industrials ex-AI and financials ex-investment banks — over the crowded AI trade. Others stay constructive on AI infrastructure, pointing to research projecting hyperscaler capex near $1.2T by 2027. Financials also get a nod tied to a steepening yield curve.
On single names, Eli Lilly draws the strongest bullish conviction in published notes; Meta is flagged as the clearest bear case on rising costs and AI-chip depreciation. Apple and a few storage names face post-earnings pressure per technical commentary.